CME Group (NASDAQ:CME) Director Jeffrey M. Bernacchi sold 3,815 shares of the business’s stock in a transaction dated Tuesday, May 22nd. The stock was sold at an average price of $161.04, for a total transaction of $614,367.60. Following the completion of the sale, the director now owns 58,607 shares in the company, valued at $9,438,071.28. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.
Shares of NASDAQ CME traded down $0.52 on Tuesday, reaching $160.86. 1,359,153 shares of the company traded hands, compared to its average volume of 1,689,019. CME Group has a fifty-two week low of $116.35 and a fifty-two week high of $171.71. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.04 and a quick ratio of 1.04. The company has a market cap of $54.24 billion, a P/E ratio of 33.72, a P/E/G ratio of 2.24 and a beta of 0.57.
CME Group (NASDAQ:CME) last posted its quarterly earnings data on Thursday, April 26th. The financial services provider reported $1.86 EPS for the quarter, beating the Zacks’ consensus estimate of $1.85 by $0.01. CME Group had a net margin of 111.45% and a return on equity of 8.48%. The company had revenue of $1.10 billion during the quarter, compared to the consensus estimate of $1.12 billion. During the same quarter in the prior year, the company posted $1.22 EPS. The company’s quarterly revenue was up 18.4% compared to the same quarter last year. equities research analysts anticipate that CME Group will post 6.79 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 25th. Stockholders of record on Friday, June 8th will be paid a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.74%. The ex-dividend date of this dividend is Thursday, June 7th. CME Group’s dividend payout ratio is currently 58.70%.
Several equities research analysts recently commented on the stock. Sandler O’Neill reiterated a “buy” rating and issued a $175.00 price objective on shares of CME Group in a research report on Friday, February 2nd. Barclays upped their target price on shares of CME Group from $170.00 to $175.00 and gave the company an “overweight” rating in a report on Friday, February 2nd. BidaskClub lowered shares of CME Group from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 28th. Bank of America upped their target price on shares of CME Group from $173.00 to $175.00 and gave the company a “buy” rating in a report on Friday, February 2nd. Finally, Citigroup restated a “buy” rating and issued a $172.00 target price (up from $155.00) on shares of CME Group in a report on Monday, January 29th. Three research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $165.57.
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Comerica Bank increased its stake in shares of CME Group by 0.4% during the 4th quarter. Comerica Bank now owns 84,159 shares of the financial services provider’s stock valued at $13,044,000 after acquiring an additional 313 shares during the last quarter. D.A. Davidson & CO. increased its stake in shares of CME Group by 1.3% during the 1st quarter. D.A. Davidson & CO. now owns 26,673 shares of the financial services provider’s stock valued at $4,314,000 after acquiring an additional 350 shares during the last quarter. Daiwa Securities Group Inc. increased its position in CME Group by 2.5% during the 4th quarter. Daiwa Securities Group Inc. now owns 14,590 shares of the financial services provider’s stock worth $2,131,000 after purchasing an additional 362 shares in the last quarter. Thrivent Financial for Lutherans increased its position in CME Group by 2.7% during the 1st quarter. Thrivent Financial for Lutherans now owns 14,201 shares of the financial services provider’s stock worth $2,297,000 after purchasing an additional 377 shares in the last quarter. Finally, BB&T Securities LLC increased its position in CME Group by 8.7% during the 4th quarter. BB&T Securities LLC now owns 4,852 shares of the financial services provider’s stock worth $708,000 after purchasing an additional 388 shares in the last quarter. 82.12% of the stock is owned by institutional investors.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.